WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 85'4301 Infant (under 12 months) mortality rate: 72
GDP / capita (US$): 143'7881 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 2'570  2'482  2'374  2'250  2'110  592  476  224 
Births 26  25  24  24  22  12  11 
Surviving infants 26  25  24  23  22  12  10 
Pop. less than 5 years 130  127  123  115  107  55  52  34 
Pop. less than 15 years 357  343  325  304  282  152  135  75 
Female 15-49 years 410  396  377  355  331  117  82  41 

Number of reported cases

(Click for retrospective incidence data for Qatar)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  30  18  46  73  160  46  314  392 
Mumps
ChartChart
  20  21  13  289  382  65 
Pertussis
ChartChart
  18  219 
Polio*
ChartChart
 
Rubella
ChartChart
  20  20  58  20  16 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Qatar)
Vaccine year result method % card seen                                                
BCG 1997  96  FHS   89  97  97  90  99  97  99*  97 
DTP1 1997  95  FHS   89  99*  95  99*  99*  95  92 
DTP3 1997  91  FHS   89  98  99  89  97  92  80  82  61 
DTP4          97  95  97 
IPV1          99*  96  82 
HepB_BD          96  95  92  93  95  99 
HepB3 1997  85  FHS   89  98  99  89  97  93  89 
Hib3          98  99  89  93  97  80 
JapEnc         
MCV1          99*  99*  99*  97  97  91  79  26 
MCV2          92  91  95  99*  99* 
MenA         
PCV1          99*  99*  99*  99*  99* 
PCV2          99*  96  98  99*  98 
PCV3          97  95  94  99*  92 
Pol3 1997  88  FHS   89  98  99  99  99*  93  91  82  61 
Rota1          99*  92  90  97  90 
RotaC          99*  92  90  97  90 
RCV1          99*  99*  99*  99*  97 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Qatar)
BCG
ChartChart
  97  97  90  98  97  99  97 
DTP1
ChartChart
  99  99  99  99  95  92  94  82 
DTP3
ChartChart
  98  99  89  97  92  80  82  61 
HepB3
ChartChart
  98  99  89  97  93  89 
HepB_BD
ChartChart
  96  95  92  93  95  99 
Hib3
ChartChart
  98  99  89  93  97  80 
IPV1
  99  96 
MCV1
ChartChart
  99  99  99  97  97  91  79  26 
MCV2
ChartChart
  92  91  95  99  99 
PCV3
ChartChart
  97  95  94  99  92 
Pol3
ChartChart
  98  99  99  99  93  91  82  61 
RCV1
ChartChart
  99  99  99  97  97  91 
RotaC
ChartChart
  99  92  90  97  90 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 4-6 years; Yes
DTaPHib 15 months; Yes
DTaPHibHepIPV 2, 4 months; Yes
DTwPHibHepB 2, 6 months; Yes
HepA 12, 18 months; Yes
HepB birth; Yes
Influenza 6 months-5 years; >65 years; Yes and with chronic illness, pregnant women, health care workers, Hajj and other travellers
MenACWY-135 conj >=2 years; Yes travellers and high risk
MMR 12, 18 months; Yes
OPV 4, 6, 18 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 15 months; Yes
Rotavirus 2, 4 months: Yes
Tdap 13-16 years; Yes
Varicella 12 months; 4-6 years Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   2011-2016  2011-2016  2011-2016  2011-2016  2011-2016  2011-2016 
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number NA    10  NA  NA     
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 80      100  100     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.